Kiffik Biomedical

KIFFIK Biomedical secures a pivotal $50 million investment from GEM Global Yield, positioning the company as a 'Unicorn-in-Waiting'

KIFFIK’s patented platform will disrupt current MedTech markets by offering real-time insights and personalized care in a way that was previously unimaginable while allowing healthcare professionals to fully diagnose, monitor, and more extensively treat patients remotely.

“I’m excited to announce a major milestone for KIFFIK Biomedical. We want to thank our new partners GEM, as we continue to deliver on our mission of bringing promising new diagnostic advancements to patients and researchers around the world.”

George Cagna

President & CEO

Play Video

KIFFIK Biomedical Featured on TV

Advancements – With Ted Danson

An educational series dedicated to the latest innovations, technologies, and sustainable breakthroughs impacting society. 

Pioneering Animal Health Through Non-Invasive Technology

Here’s a glimpse into how KIFFIK’s technology is reshaping the animal health landscape:

For questions, please reach out to Mike Gallup: